Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Size, Status and Forecast 2019-2025
Pharma and biotech companies are focusing on engaging with one-stop-shop CDMOs that have high expertise to gain a competitive edge in the market.
These CDMOs provide support through all stages of drug formulation and the development for all drug substance types. They also offer customization of packaging based on various parameters such as product safety, patient friendliness, cost efficiency, and country-specific requirements. This helps pharma and biotech firms in rapidly and safely launching their products in the market. Additionally, the assistance offered by such CDMOs is also enabling enterprises to focus more on drug discovery. CDMOs help in ensuring success for pharma and biotech companies by regularly monitoring the entire value chain of a product. They also help enterprises develop strategies to optimize capital cost during development, test drug product to meet regulatory requirements, and preserve scarce APIs.
In 2018, the global Contract Development and Manufacturing Organization (CDMO) Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Contract Development and Manufacturing Organization (CDMO) Outsourcing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Contract Development and Manufacturing Organization (CDMO) Outsourcing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Aenova Holding GmbH
Almac Group Ltd.
Catalent Inc.
FAMAR Health Care Services
FAREVA SA
Lonza Group Ltd.
Recipharm AB
Siegfried Holding AG
The Lubrizol Corp.
Thermo Fisher Scientific Inc.
Small Molecules
Biologics
Contract Development
Contract Manufacturing
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Contract Development and Manufacturing Organization (CDMO) Outsourcing status, future forecast, growth opportunity, key market and key players.
To present the Contract Development and Manufacturing Organization (CDMO) Outsourcing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Contract Development and Manufacturing Organization (CDMO) Outsourcing are as follows:
History Year: 2014-2018
2018
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
These CDMOs provide support through all stages of drug formulation and the development for all drug substance types. They also offer customization of packaging based on various parameters such as product safety, patient friendliness, cost efficiency, and country-specific requirements. This helps pharma and biotech firms in rapidly and safely launching their products in the market. Additionally, the assistance offered by such CDMOs is also enabling enterprises to focus more on drug discovery. CDMOs help in ensuring success for pharma and biotech companies by regularly monitoring the entire value chain of a product. They also help enterprises develop strategies to optimize capital cost during development, test drug product to meet regulatory requirements, and preserve scarce APIs.
In 2018, the global Contract Development and Manufacturing Organization (CDMO) Outsourcing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Contract Development and Manufacturing Organization (CDMO) Outsourcing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Contract Development and Manufacturing Organization (CDMO) Outsourcing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Aenova Holding GmbH
Almac Group Ltd.
Catalent Inc.
FAMAR Health Care Services
FAREVA SA
Lonza Group Ltd.
Recipharm AB
Siegfried Holding AG
The Lubrizol Corp.
Thermo Fisher Scientific Inc.
Market segment by Type, the product can be split into
Small Molecules
Biologics
Market segment by Application, split into
Contract Development
Contract Manufacturing
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Contract Development and Manufacturing Organization (CDMO) Outsourcing status, future forecast, growth opportunity, key market and key players.
To present the Contract Development and Manufacturing Organization (CDMO) Outsourcing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Contract Development and Manufacturing Organization (CDMO) Outsourcing are as follows:
History Year: 2014-2018
Base Year:
2018Estimated Year:
2019Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
